BRIEF published on 07/01/2024 at 11:35, 1 year 5 months ago Lupus alpha Asset Management AG Discloses Stake in Crest Nicholson Holdings Plc Shares Disclosure Takeover Code Crest Nicholson Lupus Alpha
PRESS RELEASE published on 07/01/2024 at 11:30, 1 year 5 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.74% holding in Crest Nicholson Holdings Plc. Position disclosed on 28.06.2024 as per Rule 8.3 of the Takeover Code Disclosure Takeover Code Position Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 06/28/2024 at 15:05, 1 year 5 months ago Lupus Alpha Asset Management AG Discloses Position in Crest Nicholson Holdings Plc Asset Management Form 8.3 Shareholding Crest Nicholson Lupus Alpha
PRESS RELEASE published on 06/28/2024 at 15:00, 1 year 5 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Press release: Lupus alpha Asset Management AG files Form 8.3 for dealings with Crest Nicholson Holdings Plc. Disclosure of 3.72% ownership interest Form 8.3 Disclosure Ownership Interest Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 06/27/2024 at 14:05, 1 year 5 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Takeover Code Shareholding Crest Nicholson Lupus Alpha
BRIEF published on 06/27/2024 at 14:05, 1 year 5 months ago Lupus Alpha Asset Management AG: Crest Nicholson Holdings Plc Position Disclosure Securities Transactions Disclosure Takeover Code Crest Nicholson
PRESS RELEASE published on 06/27/2024 at 14:00, 1 year 5 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses a 3.19% stake in Crest Nicholson Holdings Plc through 8.1M shares. Transactions include the purchase of 88,000 shares at 2.4 per share Disclosure Share Transactions Stake Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
PRESS RELEASE published on 06/27/2024 at 14:00, 1 year 5 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Press release: Lupus alpha Asset Management AG discloses 3.64% stake in Crest Nicholson Holdings Plc. Details on shares owned and derivative transactions provided Disclosure Stake Derivative Transactions Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
BRIEF published on 06/25/2024 at 12:35, 1 year 5 months ago Lupus Alpha Asset Management AG Discloses Position in Crest Nicholson Holdings Plc Shares Disclosure Takeover Code Crest Nicholson Lupus Alpha
PRESS RELEASE published on 06/25/2024 at 12:30, 1 year 5 months ago Form 8.3 - Lupus alpha Asset Management AG: Crest Nicholson Holdings Plc Lupus alpha Asset Management AG discloses 3.15% stake in Crest Nicholson Holdings Plc on 24th June 2024 as per Form 8.3. Details in the announcement Securities Form 8.3 Stake Disclosure Crest Nicholson Holdings Plc Lupus Alpha Asset Management AG
Published on 12/05/2025 at 02:35, 4 hours 12 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 47 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 42 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 47 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 17 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 57 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 22 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 32 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 37 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 47 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 2 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 3 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 46 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
